Circulating MicroRNAs to Predict the Risk for Metabolic Diseases in the General Population?

Diabetes - United States
doi 10.2337/dbi16-0072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

MicroRNAs in Metabolism and Metabolic Diseases

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2011English

Comparison of the Combined Obesity Indices to Predict Cardiovascular Diseases Risk Factors and Metabolic Syndrome in Northeast China

International Journal of Environmental Research and Public Health
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational HealthPollution
2016English

Insulin-Related Biomarkers to Predict the Risk of Metabolic Syndrome

International Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2013English

Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases

Genes
Genetics
2017English

MicroRNAs as Paracrine Signaling Mediators in Cancers and Metabolic Diseases

Best Practice and Research in Clinical Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2016English

Incidence and Risk Factors for Psoriasis in the General Population

Archives of Dermatology
2007English

Physical Activity, Sedentary Leisure Time, Circulating Metabolic Markers, and Risk of Major Vascular Diseases

Circulation. Genomic and precision medicine
GeneticsCardiovascular MedicineCardiology
2019English

Dysglycemia and Cardiovascular Risk in the General Population

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Circulating microRNAs in Fabry Disease

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy